Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COMSovereign Holding Corp.COMS · Entity 114048 | Director | April 26, 2023 | May 01, 2023 |
| Intellicheck, Inc.IDN · Entity 7153 | CFO, COO, Secretary & Treas | June 30, 2021 | April 15, 2022 |
| Microphase CorpNONE · Entity 169660 | Director | December 01, 2016 | December 13, 2016 |
| ProPhase Labs, Inc.PRPH · Entity 8699 | Chief Financial Officer | May 23, 2022 | May 23, 2022 |
| Q/C TECHNOLOGIES, INC.QCLS · Entity 7735 | Director | April 13, 2026 | April 15, 2026 |
| Sidus Space Inc.SIDU · Entity 6254 | CFO | December 16, 2024 | December 19, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COMSovereign Holding Corp.
Report date April 26, 2023 · Filed May 01, 2023
This filing explicitly reported no securities owned.
Intellicheck, Inc.
Report date June 30, 2021 · Filed April 15, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 | Direct | 13,526 |
Reported balance
After 2021-06-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-30 · Grant · Acquired 1,932 · Balance 13,526 F1: Of the 34,782 Restricted Stock Units granted one-third vested immediately on the date of grant and the remaining two-thirds vest quarterly over the following three years |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 | Direct | 15,458 |
Reported balance
After 2021-09-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-09-30 · Grant · Acquired 1,932 · Balance 15,458 F1: Of the 34,782 Restricted Stock Units granted one-third vested immediately on the date of grant and the remaining two-thirds vest quarterly over the following three years |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 | Direct | 17,390 |
Reported balance
After 2021-12-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-12-31 · Grant · Acquired 1,932 · Balance 17,390 F1: Of the 34,782 Restricted Stock Units granted one-third vested immediately on the date of grant and the remaining two-thirds vest quarterly over the following three years |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 | Direct | 19,322 |
Reported balance
After 2022-03-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-03-31 · Grant · Acquired 1,932 · Balance 19,322 F1: Of the 34,782 Restricted Stock Units granted one-third vested immediately on the date of grant and the remaining two-thirds vest quarterly over the following three years |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 | Direct | 24,191 |
Reported balance
After 2022-03-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-03-31 · Grant · Acquired 4,869 · Balance 24,191 F2: Of the 14,609 Restricted Stock Units granted one-third vested after year one and the remaining two-thirds shall vest quarterly over the following two years |
Filing footnotes · ownership attribution and instrument terms
F1: Of the 34,782 Restricted Stock Units granted one-third vested immediately on the date of grant and the remaining two-thirds vest quarterly over the following three years
F2: Of the 14,609 Restricted Stock Units granted one-third vested after year one and the remaining two-thirds shall vest quarterly over the following two years
Microphase Corp
Report date December 01, 2016 · Filed December 13, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, no par value per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2016-12-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 F1: Mr. White was appointed as a director effective December 1, 2016. He has not been issued any shares of Issuer's common stock to date. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. White was appointed as a director effective December 1, 2016. He has not been issued any shares of Issuer's common stock to date.
ProPhase Labs, Inc.
Report date May 23, 2022 · Filed May 23, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.74 · Expires 2029-05-09 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-05-23 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: Stock option granted as an inducement award. The option will vest over a four year period, with 12.5% vesting every six months after May 23, 2022, the date the Reporting Person's employment commenced, contingent upon his continued service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock option granted as an inducement award. The option will vest over a four year period, with 12.5% vesting every six months after May 23, 2022, the date the Reporting Person's employment commenced, contingent upon his continued service through each vesting date.
Q/C TECHNOLOGIES, INC.
Report date April 13, 2026 · Filed April 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.00 · Expires 2036-04-13 | Direct | 50,000 |
Reported balance
After 2026-04-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-13 · Grant · Acquired 50,000 · Balance 50,000 F1: The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer.
Sidus Space Inc.
Report date December 16, 2024 · Filed December 19, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 17,671 |
Reported balance
After 2024-12-16 transaction · row 1
1 source rowRow 1 · 2024-12-16 · Other · Acquired 17,671 · Balance 17,671 F1: Shares were issued as part of salary compensation. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were issued as part of salary compensation.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 13, 2026 Filed Apr 15, 2026 22:29 UTC | Q/C TECHNOLOGIES, INC. QCLS · Entity 7735 | GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001493152-26-016914 · ownership.xml · derivative · entry 1 White Billy Joe · CIK 0001546805 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-04-13 F1 · derivative.expiration_date: The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer. Read SEC document |
| November 14, 2025 Filed Nov 17, 2025 22:30 UTC | Q/C TECHNOLOGIES, INC. QCLS · Entity 7735 | GrantCommon stock | 22,839 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-023936 · ownership.xml · nonDerivative · entry 1 White Billy Joe · CIK 0001546805 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,024 F1 · price: Represents a grant of Restricted Stock Units ("RSUs"). The RSUs were granted to the Reporting Person on October 3, 2025, subject to stockholder approval of an amendment to the Issuer's Q/C Technologies, Inc. 2021 Equity Incentive Plan (the "Plan Amendment"), under which the RSUs were granted. The Issuer's stockholders approved the Plan Amendment on November 14, 2025. The RSUs vested immediately upon issuance. Read SEC document |
| October 03, 2025 Filed Oct 6, 2025 21:30 UTC | Q/C TECHNOLOGIES, INC. QCLS · Entity 7735 | GrantCommon stock | 2,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-017133 · ownership.xml · nonDerivative · entry 1 White Billy Joe · CIK 0001546805 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,185 F1 · price: Represents a grant of Restricted Stock Units ("RSUs"). The RSUs vested immediately upon grant on October 3, 2025. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 21:30 UTC | Sidus Space Inc. SIDU · Entity 6254 | OtherClass A Common Stock | 17,671 | $1.43 | $25,269.53 |
DisclosureSEC source: 0001493152-24-050787 · ownership.xml · nonDerivative · entry 1 White Billy Joe · CIK 0001546805 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,671 F1 · kind: Shares were issued as part of salary compensation. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 21:15 UTC | Sidus Space Inc. SIDU · Entity 6254 | GrantStock Options · Derivative | 25,000 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001493152-24-007401 · ownership.xml · derivative · entry 1 White Billy Joe · CIK 0001546805 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-02-20 F1 · derivative.exercise_date: 1/36th of the options vest on February 29, 2024 and such amount vests ratably at the end of each subsequent month thereafter. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 22:00 UTC | Q/C TECHNOLOGIES, INC. MYMD · Entity 7735 | GrantEmployee Stock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001493152-23-020794 · ownership.xml · derivative · entry 1 White Billy Joe · CIK 0001546805 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2028-06-07 F1 · derivative.exercise_date: The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date. Read SEC document |
| March 31, 2022 Filed Apr 15, 2022 17:16 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantRestricted Stock Unit · Derivative | 4,869 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001493152-22-010043 · ownership.xml · derivative · entry 5 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,191 Underlying: Common Stock · 4,869 shares Expires not disclosed F2 · derivative.exercise_date: Of the 14,609 Restricted Stock Units granted one-third vested after year one and the remaining two-thirds shall vest quarterly over the following two years F2 · derivative.expiration_date: Of the 14,609 Restricted Stock Units granted one-third vested after year one and the remaining two-thirds shall vest quarterly over the following two years Read SEC document |
| March 31, 2022 Filed Apr 15, 2022 17:16 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantRestricted Stock Unit · Derivative | 1,932 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001493152-22-010043 · ownership.xml · derivative · entry 4 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,322 Underlying: Common Stock · 1,932 shares Expires not disclosed F1 · derivative.exercise_date: Of the 34,782 Restricted Stock Units granted one-third vested immediately on the date of grant and the remaining two-thirds vest quarterly over the following three years F1 · derivative.expiration_date: Of the 34,782 Restricted Stock Units granted one-third vested immediately on the date of grant and the remaining two-thirds vest quarterly over the following three years Read SEC document |
| December 31, 2021 Filed Apr 15, 2022 17:16 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantRestricted Stock Unit · Derivative | 1,932 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001493152-22-010043 · ownership.xml · derivative · entry 3 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,390 Underlying: Common Stock · 1,932 shares Expires not disclosed F1 · derivative.exercise_date: Of the 34,782 Restricted Stock Units granted one-third vested immediately on the date of grant and the remaining two-thirds vest quarterly over the following three years F1 · derivative.expiration_date: Of the 34,782 Restricted Stock Units granted one-third vested immediately on the date of grant and the remaining two-thirds vest quarterly over the following three years Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 13:08 UTC | Intellicheck, Inc. IDN · Entity 7153 | PurchaseCommon Stock, $.001 par value | 1,000 | $5.25 | $5,249.00 |
DisclosureSEC source: 0001493152-21-030783 · ownership.xml · nonDerivative · entry 1 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,773 Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 21:22 UTC | Q/C TECHNOLOGIES, INC. MYMD · Entity 7735 | GrantRestricted Stock Units · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-025608 · ownership.xml · derivative · entry 1 White Billy Joe · CIK 0001546805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the "Company"). F2 · derivative.exercise_date: The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the "Required Period") and the fair market value (the "FMV") of the common stock equals or exceeds $5.00, subject to standard adjustments (the "Minimum Share Value") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control. F2 · derivative.expiration_date: The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the "Required Period") and the fair market value (the "FMV") of the common stock equals or exceeds $5.00, subject to standard adjustments (the "Minimum Share Value") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control. Read SEC document |
| September 30, 2021 Filed Apr 15, 2022 17:16 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantRestricted Stock Unit · Derivative | 1,932 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001493152-22-010043 · ownership.xml · derivative · entry 2 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,458 Underlying: Common Stock · 1,932 shares Expires not disclosed F1 · derivative.exercise_date: Of the 34,782 Restricted Stock Units granted one-third vested immediately on the date of grant and the remaining two-thirds vest quarterly over the following three years F1 · derivative.expiration_date: Of the 34,782 Restricted Stock Units granted one-third vested immediately on the date of grant and the remaining two-thirds vest quarterly over the following three years Read SEC document |
| June 30, 2021 Filed Apr 15, 2022 17:16 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantRestricted Stock Unit · Derivative | 1,932 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001493152-22-010043 · ownership.xml · derivative · entry 1 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,526 Underlying: Common Stock · 1,932 shares Expires not disclosed F1 · derivative.exercise_date: Of the 34,782 Restricted Stock Units granted one-third vested immediately on the date of grant and the remaining two-thirds vest quarterly over the following three years F1 · derivative.expiration_date: Of the 34,782 Restricted Stock Units granted one-third vested immediately on the date of grant and the remaining two-thirds vest quarterly over the following three years Read SEC document |
| April 16, 2021 Filed Apr 21, 2021 01:32 UTC | Q/C TECHNOLOGIES, INC. MYMD · Entity 7735 | Exercise / conversionRestricted Stock Units · Derivative | 109,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-009291 · ownership.xml · derivative · entry 3 White Billy Joe · CIK 0001546805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 109,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the "Company"). F3 · derivative.exercise_date: On September 11, 2020, the reporting person was granted 109,500 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control. F3 · derivative.expiration_date: On September 11, 2020, the reporting person was granted 109,500 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control. Read SEC document |
| April 16, 2021 Filed Apr 21, 2021 01:32 UTC | Q/C TECHNOLOGIES, INC. MYMD · Entity 7735 | Tax withholdingCommon Stock | 38,325 | $4.94 | $189,325.50 |
DisclosureSEC source: 0001493152-21-009291 · ownership.xml · nonDerivative · entry 2 White Billy Joe · CIK 0001546805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,175 F2 · shares: Represents 38,325 shares of RSUs withheld to pay the reporting person's tax withholding obligations incurred in connection with the vesting of 109,500 shares of RSUs on April 16, 2021. Read SEC document |
| April 16, 2021 Filed Apr 21, 2021 01:32 UTC | Q/C TECHNOLOGIES, INC. MYMD · Entity 7735 | Exercise / conversionCommon Stock | 109,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-009291 · ownership.xml · nonDerivative · entry 1 White Billy Joe · CIK 0001546805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the "Company"). F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the "Company"). Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 20:18 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantRestricted Stock Unit · Derivative | 34,782 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001493152-21-005880 · ownership.xml · derivative · entry 3 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,782 shares Expires not disclosed F3 · derivative.exercise_date: Restricted Stock Units shall vest at a rate of one-third immediately and the remaining two-thirds shall vest quarterly over the following three years F3 · derivative.expiration_date: Restricted Stock Units shall vest at a rate of one-third immediately and the remaining two-thirds shall vest quarterly over the following three years Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 20:18 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantRestricted Stock Unit · Derivative | 14,609 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001493152-21-005880 · ownership.xml · derivative · entry 2 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,609 shares Expires not disclosed F2 · derivative.exercise_date: Restricted Stock Units shall vest at a rate of one-third after year one and the remaining two-thirds shall vest quarterly over the following two years F2 · derivative.expiration_date: Restricted Stock Units shall vest at a rate of one-third after year one and the remaining two-thirds shall vest quarterly over the following two years Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 20:18 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantOption (Right to Buy) · Derivative | 13,976 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001493152-21-005880 · ownership.xml · derivative · entry 1 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,976 shares Expires 2026-03-10 F1 · derivative.exercise_date: Options shall vest at a rate of one-third after year one and the remaining two-thirds shall vest quarterly over the following two years Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 15:53 UTC | Intellicheck, Inc. IDN · Entity 7153 | Exercise / conversionOption (Right to Buy) · Derivative | 45,440 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0001493152-21-002480 · ownership.xml · derivative · entry 3 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,440 shares Expires 2021-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 15:53 UTC | Intellicheck, Inc. IDN · Entity 7153 | Exercise / conversionCommon Stock, $.001 par value | 29,140 | $1.01 | $29,431.40 |
DisclosureSEC source: 0001493152-21-002480 · ownership.xml · nonDerivative · entry 2 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Of the 45,440 options granted, 16,300 were surrendered to Intellicheck as settlement for the cashless exercise and tax withholding resulting in the acquisition of 29,140 shares. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 15:53 UTC | Intellicheck, Inc. IDN · Entity 7153 | Tax withholdingCommon Stock, $.001 par value | 45,440 | $12.04 | $547,097.60 |
DisclosureSEC source: 0001493152-21-002480 · ownership.xml · nonDerivative · entry 1 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,039 F1 · shares: Of the 45,440 options granted, 16,300 were surrendered to Intellicheck as settlement for the cashless exercise and tax withholding resulting in the acquisition of 29,140 shares. Read SEC document |
| September 11, 2020 Filed Sep 11, 2020 22:29 UTC | Q/C TECHNOLOGIES, INC. AKER · Entity 7735 | GrantRestricted Stock Unit · Derivative | 219,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-017674 · ownership.xml · derivative · entry 1 White Billy Joe · CIK 0001546805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,000 Underlying: Common Stock · 219,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the "Company"). The Company may also elect to settle the vested RSUs for cash at its discretion. F2 · derivative.exercise_date: Reporting Person was granted 219,000 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the "Plan"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause. F2 · derivative.expiration_date: Reporting Person was granted 219,000 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the "Plan"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 16:58 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantPerformance Share Units · Derivative | 50,810 | $0.00 Strike: $7.91 | $0.00 |
DisclosureSEC source: 0001493152-20-015219 · ownership.xml · derivative · entry 1 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,810 shares Expires not disclosed F1 · derivative.exercise_date: Performance Share Units become earned and vested upon the reporting person's achievement of certain performance goals as set forth by the Board of Directors. F1 · derivative.expiration_date: Performance Share Units become earned and vested upon the reporting person's achievement of certain performance goals as set forth by the Board of Directors. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 13:40 UTC | Intellicheck, Inc. IDN · Entity 7153 | Exercise / conversionOption (Right to Buy) · Derivative | 391,875 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001493152-20-012815 · ownership.xml · derivative · entry 3 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 391,875 shares Expires 2020-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 13:40 UTC | Intellicheck, Inc. IDN · Entity 7153 | Exercise / conversionCommon Stock, $.001 par value | 212,131 | $1.15 | $243,950.65 |
DisclosureSEC source: 0001493152-20-012815 · ownership.xml · nonDerivative · entry 2 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,039 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Of the 391,875 options granted, 179,744 were surrendered to Intellicheck as settlement for the cashless exercise and tax withholding resulting in the acquisition of 212,131 shares. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 13:40 UTC | Intellicheck, Inc. IDN · Entity 7153 | Tax withholdingCommon Stock, $.001 par value | 391,875 | $8.17 | $3,201,618.75 |
DisclosureSEC source: 0001493152-20-012815 · ownership.xml · nonDerivative · entry 1 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,908 F1 · shares: Of the 391,875 options granted, 179,744 were surrendered to Intellicheck as settlement for the cashless exercise and tax withholding resulting in the acquisition of 212,131 shares. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 19:32 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantRestricted Stock Unit · Derivative | 3,314 | $0.00 Strike: $5.65 | $0.00 |
DisclosureSEC source: 0001493152-20-003885 · ownership.xml · derivative · entry 1 White Billy Joe · CIK 0001546805 · CFO, COO, Secretary & Treas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,314 Underlying: Common Stock · 3,314 shares Expires not disclosed F1 · derivative.expiration_date: Restricted Stock Units became earned and vested and shares of common stock were issued in settlement of Vested Restricted Stock Units on March 11, 2020. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 14:00 UTC | Intellicheck, Inc. IDN · Entity 7153 | Exercise / conversionOption (Right to Buy) · Derivative | 18,970 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001493152-20-002280 · ownership.xml · derivative · entry 2 White Billy Joe · CIK 0001546805 · CFO, Secretary & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,970 shares Expires 2020-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 14:00 UTC | Intellicheck, Inc. IDN · Entity 7153 | Exercise / conversionCommon Stock, $.001 par value | 18,970 | $1.42 | $26,937.40 |
DisclosureSEC source: 0001493152-20-002280 · ownership.xml · nonDerivative · entry 1 White Billy Joe · CIK 0001546805 · CFO, Secretary & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2020 Filed Jan 4, 2020 00:10 UTC | Q/C TECHNOLOGIES, INC. AKER · Entity 7735 | Exercise / conversionRestricted Stock Units · Derivative | 5,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-000165 · ownership.xml · derivative · entry 2 White Billy Joe · CIK 0001546805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the "Company"). F2 · derivative.exercise_date: On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020. F2 · derivative.expiration_date: On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020. Read SEC document |
| January 01, 2020 Filed Jan 4, 2020 00:10 UTC | Q/C TECHNOLOGIES, INC. AKER · Entity 7735 | Exercise / conversionCommon Stock | 5,201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-20-000165 · ownership.xml · nonDerivative · entry 1 White Billy Joe · CIK 0001546805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the "Company"). Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 21:15 UTC | Q/C TECHNOLOGIES, INC. AKER · Entity 7735 | GrantRestricted Stock Units · Derivative | 124,827 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-004747 · ownership.xml · derivative · entry 1 White Billy Joe · CIK 0001546805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,827 Underlying: Common Stock · 124,827 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the "Company"). The Company may also elect to settle the vested RSUs for cash at its discretion. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the "Company"). The Company may also elect to settle the vested RSUs for cash at its discretion. F2 · derivative.exercise_date: Reporting Person was granted 124,827 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the "Plan"), each of which shall vest on January 1, 2020; provided that the RSUs shall vest immediately upon a Change in Control. All capitalized but undefined terms have the meanings ascribed thereto by the Plan. F2 · derivative.expiration_date: Reporting Person was granted 124,827 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the "Plan"), each of which shall vest on January 1, 2020; provided that the RSUs shall vest immediately upon a Change in Control. All capitalized but undefined terms have the meanings ascribed thereto by the Plan. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 21:53 UTC | Intellicheck, Inc. IDN · Entity 7153 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001493152-19-003041 · ownership.xml · derivative · entry 1 White Billy Joe · CIK 0001546805 · CFO, Secretary & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2024-03-06 F1 · derivative.exercise_date: The option shall become exercisable with respect to 33.33% of the shares as of the first, second and third anniversaries of the date of grant. Read SEC document |
| December 08, 2017 Filed Dec 8, 2017 18:30 UTC | Intellicheck, Inc. IDN · Entity 7153 | Exercise / conversionRestricted Stock Unit · Derivative | 8,899 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-17-014384 · form4.xml · derivative · entry 2 White Billy Joe · CIK 0001546805 · Interim CEO, CFO, Sec & Treas. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,899 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On May 19, 2016, the reporting person was granted 8,899 restricted stock units which vested on January 2, 2017. F2 · derivative.expiration_date: On May 19, 2016, the reporting person was granted 8,899 restricted stock units which vested on January 2, 2017. Read SEC document |
| December 08, 2017 Filed Dec 8, 2017 18:30 UTC | Intellicheck, Inc. IDN · Entity 7153 | Exercise / conversionCommon Stock, $.001 par value | 8,899 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-17-014384 · form4.xml · nonDerivative · entry 1 White Billy Joe · CIK 0001546805 · Interim CEO, CFO, Sec & Treas. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.